12 April 2024 - Stamford Pharmaceuticals Inc, a clinical-stage biotechnology company, announced on Thursday that it has started its locally advanced basal cell carcinoma (laBCC) trial (NCT06344052) of SP-002.The study is to assess SP-002, an adenovir...
12 April 2024 - Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the company), a late-stage biopharmaceutical company, announced on Thursday that it has received orphan drug designation for the active ingredient in SuVax, the subunit protein vaccine of r...
12 April 2024 - Algiax Pharmaceuticals, a clinical-stage biotechnology company, announced on Thursday that it has revealed an update on its ongoing Phase 2a study (NCT04429919) with lead candidate AP-325 in subjects with chronic neuropathic pain.The ...
12 April 2024 - Nuevocor, a pre-clinical stage biotechnology company, announced on Thursday that it has named Dr John Lee, MD, PhD, as its new chief Medical officer.Dr Lee, a life science executive, has more than 15 years of clinical development and ...
12 April 2024 - SparX Biopharmaceutical, a research-driven, development-stage biopharmaceutical company, announced on Thursday that it has dosed its first subject with SPX-303 injection, a First-in-Class anti-LILRB2/PD-L1 bispecific antibody drug can...